Efficacy of cough suppressants in children

https://doi.org/10.1016/S0022-3476(06)80031-4Get rights and content

To test the hypothesis that codeine and dextromethorphan are effective in alleviating the symptoms of acute cough, we conducted a randomized, controlled trial. Eligible patients were children 18 months to 12 years of age, seen in private pediatric practices, with significant night cough of less than 14 days' duration. Study patients were randomly selected to receive codeine, dextromethorphan, or placebo at bedtime for 3 consecutive nights. Outcomes were assessed by the use of a parent questionnaire rating the severity of symptoms at the initiation of therapy, and after each night of the study. Every patient had a cough score (range 0 to 4) and composite symptom score (range 0 to 9) computed for each day of the study. One hundred forty-one doses of study medication were evaluated in 49 patients, including 13 children receiving placebo, 19 dextromethorphan, and 17 codeine. Mean cough and composite symptom scores decreased in each of the three treatment groups on each day of the study; there were no significant differences. Regression analysis, with reduction in cough score as the outcome of interest, showed that neither dextromethorphan nor codeine was significantly more effective than placebo (p=0.41 and 0.70, respectively). Reduction in cough score was positively correlated with the severity of cough at the start of treatment (p=0.007). Our data suggest that, in the doses used, neither codeine nor dextromethorphan is superior to placebo in treating night cough in children.

References (18)

  • RammerL et al.

    Fatal intoxication by dextromethorphan: a report of two cases

    Forensic Sci Int

    (1988)
  • CypressBK

    Drug utilization in office visits to primary care physicians: national medical survey, 1980

    National Center for Health Statistics Advancedata

    (1982)
  • American Academy of Pediatrics Committee on Drugs

    Use of codeine and DM-containing cough syrups in pediatrics

    Pediatrics

    (1978)
  • Cough suppressants for children [Editorial]

    BMJ

    (1976)
  • HelferJ et al.

    Psychoactive abuse potential of Robitussin-DM

    Am J Psychiatry

    (1990)
  • FlemingPM

    Dependence on dextromethorphan hydrobromide

    BMJ

    (1986)
  • ShamoianCA

    Codeine and glutethimide: euphoric, addicting combination

    NY State Med J

    (1975)
  • MangurtenH et al.

    Neonatal codeine withdrawal in infants of nonaddicted mothers

    Pediatrics

    (1980)
  • GadomskiA et al.

    The need for rational therapeutics in the use of cough and cold medicine for infants

    Pediatrics

    (1992)
There are more references available in the full text version of this article.

Cited by (117)

  • The Common Cold

    2017, Principles and Practice of Pediatric Infectious Diseases
  • A randomized controlled trial of a homeopathic syrup in the treatment of cold symptoms in young children

    2016, Complementary Therapies in Medicine
    Citation Excerpt :

    The worsening of cough in the homeopathic group at the 5–10 day follow-up is difficult to explain but might be due to a rebound effect after stopping the medication. In previous randomized controlled trials on efficacy of other types of cold medications for children, we found no evidence of effectiveness of dextromethorphan or codeine in treating nighttime cough in children, nor was Echinacea found to be effective in reducing cold symptoms.3,13 However, children with colds who were treated with medicated chest rubs had significantly more improvement than those receiving placebo or no treatment.14

  • Secretory hyperresponsiveness and pulmonary mucus hypersecretion

    2014, Chest
    Citation Excerpt :

    Medications like guaifenesin (Robitussin, Mucinex) are meant to promote secretion clearance in patients with either acute or chronic airway disease but studies have failed to show that these are clinically effective.107,108 However, hypertonic saline (7% saline for CF) and dry powder mannitol have been shown to be effective in promoting sputum clearance in people with CF or non-CF bronchiectasis, probably by inducing an effective cough and drawing water into the airway surface liquid, unbinding secretions that are stuck to the epithelium.109,110 Secretions appear to stick to the airway epithelium in part because of surfactant inactivation.

View all citing articles on Scopus

Presented in part at the 31st Annual Meeting of the Ambulatory Pediatric Association, New Orleans, La., April 1991.

View full text